Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Yuanda Detian Pharmaceutical is a specialized pharmaceutical manufacturer based in Xi'an, China, and a key subsidiary of China Grand Pharmaceutical and Healthcare Holdings. The company focuses on the development and production of high-quality medicines in the fields of ophthalmology, cardiovascular disease, and emergency medicine. Its core product line includes essential treatments such as Epinephrine Hydrochloride Injection and Timolol Maleate Eye Drops. Operating with advanced manufacturing capabilities, the company serves both domestic and international markets under the broader Grandpharma umbrella. The firm is recognized for its GMP-compliant facilities and its role as a strategic production base for emergency and ophthalmic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Yuanda Detian Pharmaceutical.